Trademark: 78117247
Status Date
Friday, November 3, 2006
Filing Date
Monday, March 25, 2002
Published for Opposition
Tuesday, October 28, 2003
Abandoned Date
Friday, November 3, 2006
1 Reagents for use in scientific or medical research; purified and organic proteins and cloned DNA from humans, plants, animals, bacteria and other micro-organisms for use in the manufacture of pharmaceuticals and reagents; purified and organic proteins and cloned DNA from humans, plants, animals, bacteria and other micro-organisms and for use in scientific or medical research; cells, cell lines and cell cultures for use in scientific and medical research; transgenic and cloned animal products, namely meat, tissue, cells or secretions for use in scientific or medical research
5 -- Pharmaceutical preparations and vaccines for the treatment of myocardial infarction, cancer, multiple sclerosis, stroke, sepsis, heredity deficiency of the molecule leading to increased thrombolytic events, and heparin resistance in medical procedures; biologics; cells, cell lines and cell cultures for medical and clinical use in the production of proteins for therapeutic and diagnostic use; proteins and cloned DNA from humans, plants, animals, bacteria and other micro-organisms for use as medical therapeutic reagents; transgenic and cloned animal products, namely, meat, tissue, cells or secretions for therapeutic and diagnostic use
31 Live laboratory animals and live transgenic animals
40 Processing and purifying of antithrombin III, recombinant human albumin, decorin, cystic fibrosis transmembrane conductance regulator, prolactin and urokinase obtained from the milk of transgenic animals, and cloned animals for use in medical and scientific research and for therapeutic and diagnostic use; custom manufacture of pharmaceuticals, biopharmaceuticals, proteins, cell culture and transgenic animal products
42 Providing technical advice, research, testing and analysis in the fields of biotechnology, molecular biology, chemistry, genetics, genetic engineering, pharmaceutical production, isolation of pharmaceutical and nutritive and dietetic substances, genealogy, chemicals, and pharmaceutical drug development; pharmaceutical drug development; medical research services in the nature of medical engineering services and genetic engineering services; isolation of pharmaceutical and nutritive and dietetic substances for research purposes
44 Isolation of pharmaceutical and nutritive and dietetic substances for medical purposes; medical testing services in the nature of medical engineering and genetic engineering of cloned and transgenic animals; animal breeding; transgenic and cloned animal breeding; animal husbandry, veterinary services; veterinary surgery; providing for the care and use of transgenic or cloned animals and products there from
Jan 5, 2007
Abandonment Notice Mailed - No Use Statement Filed
Jan 5, 2007
Abandonment - No Use Statement Filed
Apr 13, 2006
Extension 3 Granted
Apr 13, 2006
Extension 3 Filed
Apr 13, 2006
Teas Extension Received
Nov 2, 2005
Extension 2 Granted
Oct 20, 2005
Extension 2 Filed
Oct 20, 2005
Teas Extension Received
Jul 29, 2005
Teas Change Of Correspondence Received
Feb 7, 2005
Extension 1 Granted
Feb 7, 2005
Extension 1 Filed
Feb 7, 2005
Teas Extension Received
Nov 2, 2004
Noa Mailed - Sou Required From Applicant
Sep 2, 2004
Case File In Ticrs
Aug 18, 2004
Extension Of Time To Oppose Process - Terminated
Dec 15, 2003
Extension Of Time To Oppose Received
Oct 28, 2003
Published For Opposition
Oct 8, 2003
Notice Of Publication
Sep 5, 2003
Approved For Pub - Principal Register
Aug 29, 2003
Examiners Amendment Mailed
Aug 25, 2003
Final Refusal Mailed
Jul 31, 2003
Previous Allowance Count Withdrawn
Jun 28, 2003
Approved For Pub - Principal Register
May 27, 2003
Correspondence Received In Law Office
May 27, 2003
Paper Received
Apr 14, 2003
Non-Final Action Mailed
Apr 4, 2003
Previous Allowance Count Withdrawn
Feb 14, 2003
Approved For Pub - Principal Register
Jan 15, 2003
Correspondence Received In Law Office
Jan 15, 2003
Paper Received
Jul 15, 2002
Non-Final Action Mailed
Jul 12, 2002
Assigned To Examiner
Trademark Alertz updated from USPTO on 2030-01-24
